Table 5 Scenario analysis varying prevalence of VLUs (optimal care service delivery Option 1)a
From: Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia
Prevalence of VLU among 60+ | 0.33% (Baseline) | 0.50% | 1% | 1.69% [18] |
|---|---|---|---|---|
Population 60+ affected with VLU at cycle 0 | 15,973 | 24,202 | 48,404 | 81,803 |
Total costs in usual care group | $2,831,006,652 | $2,954,936,472 | $3,319,435,945 | $3,822,445,216 |
Total costs in optimal care group | $1,200,427,937 | $1,246,526,209 | $1,382,109,363 | $1,569,214,116 |
Total incremental costs | -$1,630,578,715 | -$1,708,410,263 | -$1,937,326,581 | -$2,253,231,100 |
Total QALYs in usual care group | 476,090 | 499,250 | 567,367 | 661,369 |
Total QALYs in optimal care group | 504,431 | 528,959 | 601,099 | 700,653 |
Incremental QALYs | 28,341 | 29,709 | 33,732 | 39,284 |
Hospitalisations avoided | 21,677 | 22,620 | 25,394 | 29,221 |